(VFVA) Vanguard U.S. Value Factor - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US9219358051 • Mid-Cap Value

VFVA: Stocks, Equities, US, Companies

The Vanguard U.S. Value Factor ETF (BATS: VFVA) is designed to capture the potential of value investing in the U.S. equity market by targeting companies with lower valuations relative to their fundamental worth. The funds strategy revolves around identifying stocks where the market price lags behind intrinsic value, often measured through metrics like price-to-earnings (P/E) or price-to-book (P/B) ratios. By focusing on these undervalued securities, the ETF aims to deliver higher returns over the long term compared to the broader U.S. equity market.

As a mid-cap value ETF, VFVA primarily invests in mid-sized U.S. companies, which are typically more established than small-caps but still offer growth potential. The funds portfolio is diversified across various sectors, though it may lean toward industries where value investing is more prevalent, such as financials, industrials, and consumer staples. Under normal market conditions, at least 80% of the funds assets are allocated to U.S. securities, providing a high level of exposure to domestic economic trends.

With assets under management (AUM) of $836.79M USD, VFVA operates with a relatively modest size compared to some of its peers, which can provide flexibility in navigating the value segment of the market. The funds expense ratio is competitive, aligning with Vanguards reputation for cost-efficient investment products. This approach not only enhances accessibility for retail investors but also supports the funds goal of delivering value to its shareholders over time.

Looking ahead, the future outlook for VFVA hinges on the cyclical nature of value investing. As interest rates rise and inflation pressures ease, value stocks, particularly those in financials and industrials, may regain favor. Additionally, the funds focus on mid-cap companies could benefit from a potential rotation out of growth stocks into more stable, cash-flow-rich businesses. However, the persistent dominance of growth-oriented investing in the U.S. market could pose a challenge. Over the long term, VFVAs success will depend on its ability to consistently identify undervalued companies and adapt to shifting market dynamics, much like the principles outlined by Aswath Damodaran in his valuation frameworks.

Additional Sources for VFVA ETF

VFVA ETF Overview

Market Cap in USD 664m
Category Mid-Cap Value
TER 0.13%
IPO / Inception 2018-02-13

VFVA ETF Ratings

Growth Rating 73.6
Fundamental -
Dividend Rating 72.3
Rel. Strength -12.1
Analysts -
Fair Price Momentum 102.49 USD
Fair Price DCF -

VFVA Dividends

Dividend Yield 12m 2.60%
Yield on Cost 5y 6.18%
Annual Growth 5y 12.30%
Payout Consistency 99.0%

VFVA Growth Ratios

Growth Correlation 3m -90.6%
Growth Correlation 12m 28.4%
Growth Correlation 5y 88%
CAGR 5y 17.84%
CAGR/Max DD 5y 0.74
Sharpe Ratio 12m -0.15
Alpha -13.32
Beta 0.887
Volatility 41.29%
Current Volume 69.1k
Average Volume 20d 44.1k
What is the price of VFVA stocks?
As of April 28, 2025, the stock is trading at USD 107.33 with a total of 69,138 shares traded.
Over the past week, the price has changed by +5.70%, over one month by -7.44%, over three months by -13.15% and over the past year by -3.91%.
Is Vanguard U.S. Value Factor a good stock to buy?
Yes. Based on ValueRay Analyses, Vanguard U.S. Value Factor (BATS:VFVA) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.60 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VFVA as of April 2025 is 102.49. This means that VFVA is currently overvalued and has a potential downside of -4.51%.
Is VFVA a buy, sell or hold?
Vanguard U.S. Value Factor has no consensus analysts rating.
What are the forecast for VFVA stock price target?
According to ValueRays Forecast Model, VFVA Vanguard U.S. Value Factor will be worth about 115.8 in April 2026. The stock is currently trading at 107.33. This means that the stock has a potential upside of +7.92%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 115.8 7.9%